D
Crescent Biopharma, Inc. CBIO
$18.00 $0.724.17% NASDAQ
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

03/31/2026
Total Cash And Short-Term Investments 743.39%
Total Receivables --
Inventory --
Prepaid Expenses 1,464.79%
Finance Division Loans and Leases Current --
Total Finance Division Other Current Assets --
Other Current Assets --
Total Current Assets 756.31%

Total Current Assets 756.31%
Net Property, Plant & Equipment --
Long-term Investments --
Goodwill --
Total Other Intangibles --
Finance Div Loans & Leases LT --
Total Finance Div Other LT Assets --
Total Other Assets -54.25%
Total Assets 677.70%

Total Accounts Payable 87.70%
Total Accrued Expenses -65.30%
Short-term Debt --
Current Portion of Long-Term Debt/Capital Leases --
Finance Division Debt Current --
Total Finance Division Other Current Liabilities 828.72%
Total Other Current Liabilities 828.72%
Total Current Liabilities -0.64%

Total Current Liabilities -0.64%
Long-Term Debt --
Short-term Debt --
Capital Leases --
Finance Division Debt Non Current --
Total Finance Division Other Non Current Liabilities --
Total Other Liabilities --
Total Liabilities -70.48%

Common Stock & APIC 13,037.32%
Retained Earnings -490.92%
Treasury Stock & Other --
Total Common Equity 696.29%

Preferred Stock Redeemable --
Preferred Stock Non Redeemable --
Preferred Stock Convertible 0.00%
Preferred Stock, Others --
Total Preferred Equity 0.00%

Total Common Equity 696.29%
Total Preferred Equity 0.00%
Total Minority Interest --
Total Equity 802.75%